Australia markets closed

ImmunoPrecise Antibodies Ltd. (TQB.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.2000+0.0500 (+4.35%)
As of 08:11AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CAD. All numbers in thousands
Breakdown
ttm
30/04/2023
30/04/2022
30/04/2021
Total revenue
19,927
20,665
19,364
17,912
Cost of revenue
8,767
9,102
8,381
6,374
Gross profit
11,160
11,563
10,983
11,538
Operating expenses
Research development
13,158
12,280
7,663
1,974
Selling general and administrative
20,110
23,420
18,055
13,265
Total operating expenses
36,808
39,782
27,656
15,714
Operating income or loss
-25,648
-28,219
-16,673
-4,176
Interest expense
378
30
85
863
Total other income/expenses net
475
227
631
-1,238
Income before tax
-25,248
-27,752
-15,848
-5,995
Income tax expense
-46
-1,192
861
1,345
Income from continuing operations
-25,202
-26,560
-16,709
-7,340
Net income
-25,202
-26,560
-16,709
-7,340
Net income available to common shareholders
-25,202
-26,560
-16,709
-7,340
Basic EPS
-0.65
-1.07
-0.85
-0.45
Diluted EPS
-0.65
-1.07
-0.85
-0.45
Basic average shares
25,019
24,897
19,688
16,474
Diluted average shares
25,019
24,897
19,688
16,474